Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa

Código QR

Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa

S. maltophiliaS. maltophilia

Guardado en:

Detalles Bibliográficos
Autores principales:	Megan Y. Nas, Jeffrey Gabell, Nicholas P. Cianciotto
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2021
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/11076c3f347c4b37b2b99a1949cfd2b8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Stenotrophomonas maltophilia
por: Juliet L,Chrystal, et al.
Publicado: (2006)

Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species.
por: Go Hotta, et al.
Publicado: (2014)

Stenotrophomonas maltophilia en pacientes con cáncer
por: Lafourcade R,Mónica
Publicado: (2008)

Resistencia a cotrimoxazol en Stenotrophomonas maltophilia
por: Trucco A,Olivia
Publicado: (2007)

Emergence of fluoroquinolone resistance and possible mechanisms in clinical isolates of Stenotrophomonas maltophilia from Iran
por: Akram Azimi, et al.
Publicado: (2021)

Acanthamoeba and Stenotrophomonas maltophilia keratitis with fungal keratitis in the contralateral eye
por: Thomas F Mauger, et al.
Publicado: (2010)

Stenotrophomonas maltophilia isolated from gasoline-contaminated soil is capable of degrading methyl tert-butyl ether
por: Alfonso-Gordillo,Guadalupe, et al.
Publicado: (2016)

Stenotrophomonas maltophilia endogenous endophthalmitis: clinical presentation, antibiotic susceptibility, and outcomes
por: Chhablani J, et al.
Publicado: (2014)

Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung
por: Hattie Chung, et al.
Publicado: (2017)

The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
por: Matthias I. Gröschel, et al.
Publicado: (2020)

Stenotrophomonas maltophilia endophthalmitis following cataract surgery: clinical and microbiological results
por: Chang JS, et al.
Publicado: (2013)

Degradation of methomyl by the novel bacterial strain Stenotrophomonas maltophilia M1
por: Mohamed,Mervat S
Publicado: (2009)

Post-secretional activation of Protease IV by quorum sensing in Pseudomonas aeruginosa
por: Jungmin Oh, et al.
Publicado: (2017)

The DSF quorum sensing system controls the positive influence of Stenotrophomonas maltophilia on plants.
por: Peyman Alavi, et al.
Publicado: (2013)

Effect of antibiotic therapy on the prognosis of ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
por: Bérénice Puech, et al.
Publicado: (2021)

Stenotrophomonas Maltophilia: A rare cause of left sided prosthetic valve endocarditis
por: Anupam Dey, et al.
Publicado: (2021)

Twitching motility of Stenotrophomonas maltophilia under iron limitation: In-silico, phenotypic and proteomic approaches
por: V. Kalidasan, et al.
Publicado: (2020)

Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate
por: Kimberly K. Kajihara, et al.
Publicado: (2021)

Effect of urea-N on growth and indoleacetic acid production of Stenotrophomonas maltophilia (Sb16) isolated from rice growing soils in Malaysia
por: Othman,Radziah, et al.
Publicado: (2013)

The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
por: Emma Hennessy, et al.
Publicado: (2014)

A pediatric case of cellulitis caused by Stenotrophomonas maltophilia with subcutaneous microvascular thrombosis and diffuse hemorrhage
por: Emi Inoue, et al.
Publicado: (2021)

BsmR degrades c-di-GMP to modulate biofilm formation of nosocomial pathogen Stenotrophomonas maltophilia
por: Wei Liu, et al.
Publicado: (2017)

The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia.
por: Alvaro Hernández, et al.
Publicado: (2011)

Structural basis for an exceptionally strong preference for asparagine residue at the S2 subsite of Stenotrophomonas maltophilia dipeptidyl peptidase 7
por: Akihiro Nakamura, et al.
Publicado: (2021)

Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among <named-content content-type="genus-species">Stenotrophomonas maltophilia</named-content> Isolates in the United States
por: Maria F. Mojica, et al.
Publicado: (2019)

Differentiation between Pseudomonas and Stenotrophomonas Species Isolated from Fish Using Molecular and MALDI-TOF Method
por: Aksentijević Ksenija, et al.
Publicado: (2016)

Bacteria-specific pro-photosensitizer kills multidrug-resistant Staphylococcus aureus and Pseudomonas aeruginosa
por: Min Lu, et al.
Publicado: (2021)

Antibacterial and cytotoxic efficacy of extracellular silver nanoparticles biofabricated from chromium reducing novel OS4 strain of Stenotrophomonas maltophilia.
por: Mohammad Oves, et al.
Publicado: (2013)

Relationship between type III secretion toxins, biofilm formation, and antibiotic resistance in clinical Pseudomonas aeruginosa isolates
por: Safoura Derakhshan, et al.
Publicado: (2019)

Impacts of Penicillin Binding Protein 2 Inactivation on β-Lactamase Expression and Muropeptide Profile in <italic toggle="yes">Stenotrophomonas maltophilia</italic>
por: Yi-Wei Huang, et al.
Publicado: (2017)

Pseudomonas fluorescens F113 type VI secretion systems mediate bacterial killing and adaption to the rhizosphere microbiome
por: David Durán, et al.
Publicado: (2021)

Mechanism of effector capture and delivery by the type IV secretion system from Legionella pneumophila
por: Amit Meir, et al.
Publicado: (2020)

Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa
por: Sonika Sharma, et al.
Publicado: (2021)

The Rickettsial Ankyrin Repeat Protein 2 Is a Type IV Secreted Effector That Associates with the Endoplasmic Reticulum
por: Stephanie S. Lehman, et al.
Publicado: (2018)

Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa.
por: Claire Gendrin, et al.
Publicado: (2012)

Potential application of protease isolated from Pseudomonas aeruginosa PD100
por: Najafi,Mohsen Fathi, et al.
Publicado: (2005)

Novel Type III Effectors in <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
por: David Burstein, et al.
Publicado: (2015)

Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE
por: Valerio Baldelli, et al.
Publicado: (2020)

Antimicrobial Peptide Exposure Selects for Resistant and Fit <named-content content-type="genus-species">Stenotrophomonas maltophilia</named-content> Mutants That Show Cross-Resistance to Antibiotics
por: Paula Blanco, et al.
Publicado: (2020)

Molecular analysis of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
por: Dariusz Jarych, et al.
Publicado: (2021)